Abstract
Mutual interactions were investigated between intracellular parasitic bacterium Francisella tularensis (F.t.; highly virulent bacterium responsible for tularemia, replicating within the host macrophages) and murine macrophage-like cell line J774. Recombinant murine lymphokine INF-γ and/or LPS derived from E. coli were determined to stimulate in vitro antimicrobial activity of macrophage-like J774 cell line against the live vaccine strain (LVS) of F.t. through their ability to produce proinflammatory cytokines and chemokines. F.t. infection up-regulated IL-12 p40 production and down-regulated TNF-α production by stimulated macrophages; on the other hand, F.t. infection did not affect the production of IL-8, IL-6, MCP-5, and RANTES by stimulated macrophages. This showed that F.t. infection modulates the cytokine synthesis by J774 macrophage cell line.
Similar content being viewed by others
Abbreviations
- BSA:
-
fetal bovine serum (bovine serum albumin)
- CFU:
-
colony-forming units
- DMEM:
-
Dulbecco’s modified Eagle medium
- ELISA:
-
enzyme-linked immunosorbent assay
- F.t. :
-
Francisella tularensis
- FasL:
-
Fas ligand (chemokines)
- IL:
-
interleukin
- IL-12 p40:
-
IL-12 p40 subunit
- LPS:
-
lipopolysaccharide
- LVS:
-
live vaccine strain
- MCP-5:
-
monocyte chemotactic protein 5
- MIP 1α/β:
-
macrophage inflammatory protein
- NFκB:
-
nuclear factor-κB
- NK:
-
natural killer (cells)
- PAMP(s):
-
pathogen-associated molecular pattern(s)
- PBS:
-
phosphate-buffered saline
- PRR(s):
-
pattern recognition receptor(s)
- RANTES:
-
regulated upon activation, normal T cell expressed, and presumably secreted
- TLR:
-
Toll-like receptors
- TNF-α:
-
tumor necrosis factor α
References
Anthony L.S.D., Morrissey P.J., Nano F.E.: Growth inhibition of Francisella tularensis live vaccine strain by INF-γ-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism. J.Immunol.148, 1829–1834 (1992).
Appay V., Rowland-Jones S.L.: RANTES: a versatile and controversial chemokine. Trends Immunol.22, 83–87 (2001).
van Coillie E., van Damme J., Opdenakker G.: The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev.10, 61–86 (1999).
Colombo M.P., Trinchieri G.: Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev.13, 155–168 (2002).
Dinarello C.A.: Interleukin-18. Methods19, 121–132 (1999).
Duenas A.I., Aceves M., Orduna A., Díaz R., Crespo M.S., García-Rodríguez C.: Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptors 4 with much lower potency than E. coli LPS. Internat.Immunol.18, 785–795 (2006).
Fortier A.H., Polsinelli T., Green S.J., Nacy C.A.: Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules. Infect.Immun.60, 817–825 (1992).
Fortier A.H., Leiby D.A., Narayanan R.B., Asafoadjei E., Crawford R.M., Nacy C.A., Meltzer M.S.: Growth of Francisella tularensis LVS in macrophages: the acid intracellular compartment provides essential iron required for growth. Infect.Immun.63, 1478–1483 (1995).
van Furth R., van Dissel J.T.: Interferon gamma does not enhance the bactericidal activity of murine macrophages. Agents Actions26, 158–159 (1989).
Golovliov I., Sandström G., Ericsson M., Sjöstedt A., Tärnvik A.: Cytokine expression in the liver during the early phase of murine tularemia. Infect.Immun.63, 534–538 (1995).
Golovliov I., Kuoppa K., Sjöstedt A., Tärnvik A., Sandström G.: Cytokine expression in the liver of mice infected with a highly virulent strain of Francisella tularensis. FEMS Immunol.Med.Microbiol.13, 239–244 (1996).
Golovliov I., Baranov V., Krocova Z., Kovarova H., Sjöstedt A.: An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells. Infect.Immun.71, 5940–5950 (2003a).
Golovliov I., Sjöstedt A., Mokrievich A., Pavlov V.: A method for allelic replacement in Francisella tularensis. FEMS Microbiol. Lett.222, 273–280 (2003b).
Hrstka R., Stulík J., Vojtěšek B.: The role of MAPK signaling pathway during Francisella tularensis LVS infection-induced apoptosis in murine macrophages. Microbes Infect.7, 619–625 (2005).
Hrstka R., Kročová Z., Černý J., Vojtěšek B., Macela A., Stulík J.: Francisella tularensis strain LVS resides in MHC II-positive autophagic vacuoles in macrophages. Folia Microbiol.52, 631–636 (2007).
Isherwood K.E., Titball R.W., Davies D.H., Felgner P.L., Morrow J.W.: Vaccination strategies for Francisella tularensis. Adv. Drug Deliv.Rev.57, 1403–1414 (2005).
Janovská S., Pávková I., Reichelová M., Hubálek M., Stulík J., Macela A.: Proteomic analysis of antibody response in a case of laboratory-acquired infection with Francisella tularensis subsp. tularensis. Folia Microbiol.52, 194–198 (2007).
Kmoníčková E., Zídek Z.: Quantitative aspects of lipopolysaccharide and cytokine requirements to generate nitric oxide in macrophages from LPS-hyporesponsive (Lpsd) C3H/HeJ mice. Folia Microbiol.49, 737–744 (2004).
Lachheb J., Chelbi H., Hamzaoui K., Hamzaoui A.: Association between RANTES polymorphisms and asthma severity among Tunisien children. Human Immunol.68, 675–680 (2007).
Lai X.H., Golovliov I., Sjöstedt A.: Francisella tularensis induced cytophatogenicity and apoptosis in murine macrophages via a mechanism that requires intracellular bacterial multiplication. Infect.Immun.69, 4691–4694 (2001).
Loegering D.J., Drake J.R., Banas J.A., Mcnealy T.L., Mc Arthur D.G., Webster L.M., Lennartz M.R.: Francisella tularensis LVS growth in macrophages has reduced ability to stimulate the secretion of inflammatory cytokines by macrophages in vitro. Microb.Pathogen41, 218–225 (2006).
Majumdar S., Gupta R., Dogra N.: Interferon-γ- and lipopolysaccharide-induced tumor necrosis factor-α is required for nitric oxide production: tumor necrosis factor-α and nitric oxide are independently involved in the killing of Mycobacterium microti in interferon-γ- and lipopolysaccharide-treated J774A.1 cells. Folia Microbiol.45, 457–463 (2000).
Mittal J., Dobra N., Vohra H., Majumdar S.: Effects of prostaglandin E2 and nitric oxide inhibitors on the expression of interleukin-10, interleukin-12 and MHC class-II molecules in Mycobacterium microti-infected and interferon-γ-treated mouse peritoneal macrophages. Folia Microbiol.46, 259–264 (2001).
Moller A.S.W., Ovstenbo R., Haug K.B.F., Joo G.B., Westvik A.B., Kierulf P.: Chemokine production and pattern recognition receptor (PRR) expression in whole blood stimulated with pathogen-associated molecular patterns (PAMPs). Cytokine32, 304–315 (2005).
Murray H.W.: γ-Interferon, cytokine-induced macrophage activation, and antimicrobial host defense. Diagn.Microbiol.Infect.Dis.13, 411–421 (1990).
Pohanka M., Skládal P.: Piezoelectric immunosensor for the direct and rapid detection of Francisella tularensis. Folia Microbiol.52, 325–330 (2007).
Pohanka M., Skládal P.: Bacillus anthracis, Francisella tularensis and Yersinia pestis. The most important bacterial warfare agents — review. Folia Microbiol.54, 263–272 (2009).
Polsinelli T., Meltzer M.S., Fortier A.H.: Nitric oxide-independent killing of Francisella tularensis by IFN-γ-stimulated murine alveolar macrophages. J.Immunol.153, 1238–1245 (1994).
Reilly T.J., Felts R.L., Henzl M.T., Calcutt M.J., Tanner J.J.: Characterization of recombinant Francisella tularensis acid phosphatase A. Protein Exp.Purif.45, 132–141 (2006).
Schroder K., Hertzog P.J., Ravasi T., Hume D.A.: Interferon-γ: an overview of signals, mechanisms and functions. J.Leukoc.Biol.75, 163–189 (2004).
Sjöstedt A.: Intracellular survival mechanisms of Francisella tularensis, a stealth pathogen. Microb.Infect.8, 561–567 (2006).
Stenmark S., Sunnemark D., Bucht A., Sjöstedt A.: Rapid local expression of interleukin-12, tumor necrosis factor α, and γ interferon after cutaneous Francisella tularensis infection in tularemia-immune mice. Infect.Immun.67, 1789–1797 (1999).
Stuyt R.J.L., Kim S.H., Reznikov L.L., Fantuzzi G., Novick D., Rubinstein M., Kullberg B.J., van der Meer J.W.M., Dinarello C.H.A., Netea M.G.: Regulation of Staphylococcus-induced INF-γ in whole human blood: the role of endogenous IL-18, IL-12, IL-1, and TNF. Cytokine21, 65–73 (2003).
Telepnev M., Golovliov I., Grundström T., Tärnvik A., Sjörstedt A.: Francisella tularensis inhibits Toll-like receptor-mediated activation of intracellular signaling and secretion of TNF-α and IL-1 from murine macrophages. Cellular Microbiol.5, 41–51 (2003).
Telepnev M., Golovliov I., Sjöstedt A.: Francisella tularensis LVS initially activates but subsequently down-regulates intracellular signaling and cytokine secretion in mouse monocytic and human peripheral blood mononuclear cells. Microb.Pathogenesis38, 239–247 (2005).
Xing Z., Zganiacz A., Satosuosso M.: Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-α and nitric oxide macrophages via IFN-γ induction. J.Leukoc.Biol.68, 897–902 (2000).
Zlotnik A., Yoshie O.: Chemokines: a new classification system and their role in immunity. Immunity12, 121–127 (2000).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Holicka, M., Novosad, J., Kudlova, M. et al. J774 macrophage-like cell line cytokine and chemokine patterns are modulated by Francisella tularensis LVS strain infection. Folia Microbiol 55, 191–200 (2010). https://doi.org/10.1007/s12223-010-0028-3
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-010-0028-3